Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)

NCT03760575 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Mesotheliomas Pleural

Interventions

DRUG: Pembrolizumab
PROCEDURE: Indocyanine Green (ICG) Image-Guided Surgery
DRUG: Cisplatin
DRUG: Pemetrexed

Sponsor

Abramson Cancer Center at Penn Medicine